APMD
Apnimed, Inc. Common Stock (APMD)
Healthcare • NASDAQ • $17.76-2.66%
Key Fundamentals
- Symbol
- APMD
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $17.76
- Daily Change
- -2.66%
- Market Cap
- $771.00M
- Trailing P/E
- 2.57
- Forward P/E
- -4.66
- 52W High
- $35.29
- 52W Low
- $16.12
- Analyst Target
- $50.33
- Dividend Yield
- 0.00%
- Beta
- N/A
About Apnimed, Inc. Common Stock
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Company websiteResearch APMD on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.